YEAR | COMPANY | POSITION | SALARY | INCREMENT |
---|---|---|---|---|
2024 | Neogenomics Inc. | Independent Director | 318.9 K | 0.4 % |
2024 | DMC Global Inc | Independent Director | 213.1 K | - |
2023 | Neogenomics Inc. | Independent Director | 317.5 K | 18.0 % |
2023 | Hookipa Pharma Inc | Independent Director | 15 K | -81.9 % |
2023 | DMC Global Inc | Independent Director | - | - |
2022 | Neogenomics Inc. | Independent Director | 269.0 K | 9.3 % |
2022 | DMC Global Inc | Independent Director | 175.0 K | -0.0 % |
2022 | Hookipa Pharma Inc | Independent Director | 82.9 K | -50.5 % |
2022 | Aprea Therapeutics Inc | Independent Director | 19.2 K | -87.3 % |
2022 | Aprea Therapeutics Inc | Independent Director | - | - |
2021 | Neogenomics Inc. | Independent Director | 246.1 K | - |
2021 | DMC Global Inc | Independent Director | 175.0 K | 89.2 % |
2021 | Hookipa Pharma Inc | Independent Director | 167.4 K | 30.7 % |
2021 | Aprea Therapeutics Inc | Independent Director | 151.4 K | -24.3 % |
2020 | Aprea Therapeutics Inc | Independent Director | 199.9 K | - |
2020 | Hookipa Pharma Inc | Independent Director | 128.1 K | -43.7 % |
2020 | DMC Global Inc | Independent Director | 92.5 K | - |
2020 | Neogenomics Inc. | Independent Director | - | - |
2019 | Hookipa Pharma Inc | Independent Director | 227.5 K | - |
2018 | Hookipa Pharma Inc | Director | - | - |